M. Laversanne

Oncology · 2015–2024

A researcher in the Science corpus: 12 papers; trusts 4 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

• Oncology — 132 citations into it

Whom M. Laversanne trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. J. Ferlay
2. F. Bray

Papers from M. Laversanne's perspective

Ordered by how strongly the researchers M. Laversanne trusts endorse each paper. Same corpus, a different order for every researcher.

1. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.
2. International variation in prostate cancer incidence and mortality rates. (European Urology)
3. Global patterns and trends in colorectal cancer incidence and mortality (Gut)
4. Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study (British medical journal)
5. Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends. (European Urology)
6. Lung adenocarcinoma promotion by air pollutants (Nature)
7. Global burden of gastric cancer: epidemiological trends, risk factors, screening and prevention (Nature Reviews Clinical Oncology)
8. The global burden of lung cancer: current status and future trends (Nature Reviews Clinical Oncology)
9. Worldwide Thyroid-Cancer Epidemic? The Increasing Impact of Overdiagnosis. (New England Journal of Medicine)
10. Breast-cancer screening--viewpoint of the IARC Working Group. (New England Journal of Medicine)

Their papers

• The GLOBOCAN 2022 cancer estimates: Data sources, methods, and a snapshot of the cancer burden worldwide (2024) — 746 citations
• Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries (2024) — 29,832 citations
• Current and future burden of breast cancer: Global statistics for 2020 and 2040 (2022) — 2,868 citations
• The global landscape of esophageal squamous cell carcinoma and esophageal adenocarcinoma incidence and mortality in 2020 and projections to 2040: New estimates from GLOBOCAN 2020. (2022) — 975 citations
• The current and future incidence and mortality of gastric cancer in 185 countries, 2020–40: A population-based modelling study (2022) — 658 citations
• Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN (2022) — 2,060 citations
• Global Burden of Cutaneous Melanoma in 2020 and Projections to 2040. (2022) — 1,155 citations
• Global burden of primary liver cancer in 2020 and predictions to 2040 (2022) — 1,853 citations
• Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries (2021) — 96,839 citations
• The ever‐increasing importance of cancer as a leading cause of premature death worldwide (2021) — 2,134 citations
• Global patterns and trends in colorectal cancer incidence and mortality (2016) — 4,629 citations
• International variations and trends in renal cell carcinoma incidence and mortality. (2015) — 915 citations